2.Predicting Metabolic Syndrome Using Anthropometric Indices among Chinese Adolescents with Different Nutritional Status: A Multicenter Cross-sectional Study.
Ya Mei LI ; Zhi Yong ZOU ; Ying Hua MA ; Jia You LUO ; Jin JING ; Xin ZHANG ; Chun Yan LUO ; Hong WANG ; Hai Ping ZHAO ; De Hong PAN ; Mi Yang LUO
Biomedical and Environmental Sciences 2021;34(9):673-682
Objective:
To evaluate the predictive performance of anthropometric indices for metabolic syndrome (MetS) among Chinese adolescents with different nutritional status.
Methods:
We recruited 9,513 adolescents aged 10-18 years from seven provinces in China during September 2014. Anthropometric indices and blood pressure were measured at recruitment, and blood samples were collected for determining fasting plasma glucose and lipid profile. Receiver operating characteristic (ROC) analyses were used to assess the predictive performance of anthropometric indices, including body mass index (BMI) percentile, waist circumference percentile, waist-height ratio, and waist-hip ratio.
Results:
Overall, the four anthropometric indices showed good accuracy for predicting MetS with areas under ROC curves (AUCs) ranging from 0.86 to 0.94; similar AUCs ranging from 0.73 to 0.99 were observed for participants with normal weight. The performance of all four indices was poor in overweight and obese participants, with AUCs ranging from 0.66 to 0.77 and from 0.60 to 0.67, respectively. Waist circumference showed relatively better performance in all the subgroup analyses.
Conclusions
We suggest using anthropometric indices with the cutoff values presented here for predicting MetS in the overall and normal-weight adolescent population, but not in the overweight and obese adolescent population where more specific screening tests are required.
Adolescent
;
Asians
;
Body Weights and Measures
;
Child
;
China
;
Cross-Sectional Studies
;
Female
;
Humans
;
Male
;
Metabolic Syndrome/diagnosis*
;
Nutritional Status
;
Randomized Controlled Trials as Topic
3.Feasibility of Robot-Assisted Gait Training with an End-Effector Type Device for Various Neurologic Disorders
Soojin CHOI ; Seong Woo KIM ; Ha Ra JEON ; June Sung LEE ; Dong Yeong KIM ; Jang Woo LEE
Brain & Neurorehabilitation 2020;13(1):6-
Robots are being used to assist the recovery of walking ability for patients with neurologic disorders. This study aimed to evaluate the feasibility and functional improvement of training with robot-assisted gait training (RAGT) using the Morning Walk®, an end-effector type robot using footplates and saddle seat support. A total of 189 individuals (65.1% men, 34.9% women; mean age, 53.2 years; age range: 5–87 years) with brain lesions, spinal cord injuries, Parkinson's disease, peripheral neuropathies, and pediatric patients were involved in this retrospectively registered clinical trial. Each participant performed 30 minutes of RAGT, five times a week, for a total of 24 sessions. Failure was defined as an inability to complete all 24 sessions, and the reasons for discontinuation were analyzed. Parameters of Medical Research Council scales and Functional Ambulation Categories were analyzed before and after RAGT training. Among the 189 patients, 22 (11.6%) failed to complete the RAGT. The reasons included decreased cooperation, musculoskeletal pain, saddle seat discomfort, excessive body-weight support, joint spasticity or restricted joint motion, urinary incontinence from an indwelling urinary catheter, and fatigue. Comparison between the pre- and post-training motor and ambulatory functions showed significant improvement. The result of the study indicates that the Morning Walk® is feasible and safe and useful for functional improvement in patients with various neurologic disordersTRIAL REGISTRATION: Clinical Research Information Service Identifier: KCT0003627
Brain
;
Fatigue
;
Female
;
Gait
;
Humans
;
Information Services
;
Joints
;
Male
;
Muscle Spasticity
;
Musculoskeletal Pain
;
Nervous System Diseases
;
Parkinson Disease
;
Peripheral Nervous System Diseases
;
Retrospective Studies
;
Spinal Cord Injuries
;
Urinary Catheters
;
Urinary Incontinence
;
Walking
;
Weights and Measures
4.Determinant of Quality of Life in Patients with Chronic Cerebral Infarct
Yujin LEE ; Joon Sung KIM ; Bo Young HONG ; Jung Geun PARK ; Jae Wan YOO ; Kyoung Bo LEE ; Tae Woo KIM ; Seong Hoon LIM
Brain & Neurorehabilitation 2020;13(1):4-
This study investigated how physical and cognitive function and psychological factors affected the health-related quality of life (HRQoL, hereafter HQ) of stroke patients in South Korea. The study enrolled 32 right-handed subjects with chronic cerebral infarction with disability and preserved cognitive function (Mini-Mental State Examination ≥ 20). Physical disability was assessed using the modified Rankin Scale (mRS) and Korean modified Barthel Index (KMBI). Quality of life was measured using the World Health Organization Quality of Life-Abbreviated form (WHOQOL-BREF, hereafter WB) and the 36-Item Short-form Health Survey (SF-36) in face-to-face interviews. Psychological distress was investigated using the Beck Depression Inventory Scale-II. The associations of each domain of WB and SF-36 were investigated using Pearson correlation analyses. Physical disability was negatively correlated with HQ in the SF-36. The physical function and bodily pain scales of the SF-36 were negatively correlated with physical disability. The general health domain of the SF-36 was negatively correlated with psychological scores. Emotional status was associated with physical health, social relationships, and general health in HQ. In summary, the severity of physical disability was associated with the patient's general and physical health and body pain. These findings suggest the importance of psychological, cognitive, and physiological interventions for improving the quality of life of patients after cerebral infarction.
Cerebral Infarction
;
Cognition
;
Depression
;
Health Surveys
;
Humans
;
Korea
;
Psychology
;
Quality of Life
;
Stroke
;
Weights and Measures
;
World Health Organization
5.The Relations between Sitting Balance and Functional Recovery according to Characteristics of the Stroke Patients
Da Sol KIM ; Myoung Hwan KO ; Yu Hui WON ; Sung Hee PARK ; Jeong Hwan SEO ; Gi Wook KIM
Brain & Neurorehabilitation 2020;13(1):2-
We measured the difference of sitting pressure between the affected and unaffected sides (DSPAU) using sitting pressure measured with a force platform to identify sitting imbalance. The aim of this study is to investigate the relations between sitting balance and functional status or parameters according to characteristics stroke patients. We examine changes in DSPAU and functional assessment before and after a 3 week of rehabilitation in hemiplegic stroke patients (n = 73). These pre- and post-treatment data according to stroke characteristics, and correlations between the DSPAU and functional scales were analyzed. The DSPAU was greater in the non-ambulatory group compared to the ambulatory group, in patients who scored lower in the Medical Research Council (MRC) scores, and in patients whose the MRC scores for the lower limbs were lower than of the upper limbs. We observed that a decrease in the DSPAU was associated with an improvement in functional assessment parameters following rehabilitation. Further, changes in DSPAU were significantly correlated to the Modified Barthel Index. We observed that a decrease in DSPAU was associated with an improvement in functional parameters following rehabilitation. In conclusion, repeated measurements of sitting balance using DSPAU may be helpful to predict motor and functional recovery in stroke patient with hemiplegia.
Hemiplegia
;
Humans
;
Lower Extremity
;
Postural Balance
;
Recovery of Function
;
Rehabilitation
;
Stroke
;
Upper Extremity
;
Weights and Measures
6.Quality of Life and Emotional Strain in Caregivers of Patients with Multiple Sclerosis.
Petros PETRIKIS ; Anastasia BALDOUMA ; Aristeidis H KATSANOS ; Spyridon KONITSIOTIS ; Sotirios GIANNOPOULOS
Journal of Clinical Neurology 2019;15(1):77-83
BACKGROUND AND PURPOSE: This study aimed was to measure the quality of life, fatigue, stress, and depression in a consecutive sample of caregivers of multiple sclerosis (MS) patients. METHODS: We included data from 131 consecutive caregivers of MS patients [age=51.2±12.8 years (mean±SD), males=53.4%, duration of caregiving=10.0±6.3 years]. We assessed the quality of life, fatigue, stress, and depression of the caregivers using the 36-item Short Form Health Survey, Krupp Fatigue Severity Scale, Kingston Caregiver Stress Scale, and Hamilton Scale for Depression, respectively. The disability status of the patients was assessed using the Kurtzke Expanded Disability Status Scale. We used linear regression models to identify possible correlations between all of the aforementioned scales, while multivariable logistic regression models were employed to assess the correlations of caregiver fatigue with caregiver characteristics and patient disability. RESULTS: The linear regression analyses revealed that caregiver fatigue was positively associated with stress and negatively correlated with both physical health status and mental health status. Caregiver stress was positively associated with depression and negatively correlated with both physical health status and mental health status. Depression was negatively correlated with both caregiver physical health status and mental health status. In multivariable logistic regression analysis, caregiver fatigue was found to be independently associated with education status [odds ratio (OR)=0.61, 95% CI=0.37 to 0.99], history of chronic disease (OR=5.52, 95% CI=1.48 to 20.55), other chronic diseases in the family (OR=7.48, 95% CI=1.49 to 37.47), and the disability status of the patient (OR=1.36, 95% CI=1.03 to 1.80). CONCLUSIONS: Fatigue, stress, and depression in caregivers of MS patients are negatively correlated with their physical health status and mental health status. Caregiver fatigue is independently associated with education status, history of chronic disease, other chronic disease in the family, and patient disability.
Anxiety
;
Caregivers*
;
Chronic Disease
;
Depression
;
Education
;
Fatigue
;
Health Surveys
;
Humans
;
Linear Models
;
Logistic Models
;
Mental Health
;
Multiple Sclerosis*
;
Quality of Life*
;
Weights and Measures
7.Meta-analysis of the Diagnostic Test Accuracy of Pediatric Inpatient Fall Risk Assessment Scales.
Eun Joo KIM ; Ji Young LIM ; Geun Myun KIM ; Mi Kyung LEE
Child Health Nursing Research 2019;25(1):56-64
PURPOSE: This study was conducted to obtain data for the development of an effective fall risk assessment tool for pediatric inpatients through a systematic review and meta-analysis of the diagnostic test accuracy of existing scales. METHODS: A literature search using Medline, Science Direct, CINAHL, EMBASE, and the Cochrane Library was performed between March 1 and 31, 2018. Of 890 identified papers, 10 were selected for review. Nine were used in the meta-analysis. Stata version 14.0 was used to create forest plots of sensitivity and specificity. A summary receiver operating characteristic curve was used to compare all diagnostic test accuracies. RESULTS: Four studies used the Humpty Dumpty Falls Scale. The most common items included the patient's diagnoses, use of sedative medications, and mobility. The pooled sensitivity and specificity of the nine studies were .79 and .36, respectively. CONCLUSION: Considering the low specificity of the pediatric fall risk assessment scales currently available, there is a need to subdivide scoring categories and to minimize items that are evaluated using nurses' subjective judgment alone. Fall risk assessment scales should be incorporated into the electronic medical record system and an automated scoring system should be developed.
Accidental Falls
;
Diagnosis
;
Diagnostic Tests, Routine*
;
Electronic Health Records
;
Forests
;
Humans
;
Inpatients*
;
Judgment
;
Pediatrics
;
Risk Assessment*
;
ROC Curve
;
Sensitivity and Specificity
;
Weights and Measures*
8.Treatment Patterns and Changes in Quality of Life during First-Line Palliative Chemotherapy in Korean Patients with Advanced Gastric Cancer.
Jin Won KIM ; Jong Gwang KIM ; Byung Woog KANG ; Ik Joo CHUNG ; Young Seon HONG ; Tae You KIM ; Hong Suk SONG ; Kyung Hee LEE ; Dae Young ZANG ; Yoon Ho KO ; Eun Kee SONG ; Jin Ho BAEK ; Dong‐Hoe KOO ; So Yeon OH ; Hana CHO ; Keun Wook LEE
Cancer Research and Treatment 2019;51(1):223-239
PURPOSE: The purpose of this study was to evaluate chemotherapy patterns and changes in quality of life (QOL) during first-line palliative chemotherapy for Korean patients with unresectable or metastatic/recurrent gastric cancer (GC). MATERIALS AND METHODS: Thiswas a non-interventional, multi-center, prospective, observational study of 527 patients in Korea. QOL assessments were conducted using the European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaires (QLQ)-C30 and QLQ-STO22 every 3 months over a 12-month period during first-line palliative chemotherapy. The specific chemotherapy regimens were selected by individual clinicians. RESULTS: Most patients (93.2%) received combination chemotherapy (mainly fluoropyrimidine plus platinum) as their first-line palliative chemotherapy. The median progression-free survival and overall survival were 8.2 and 14.8 months, respectively. Overall, “a little” changes (differences of 5-10 points from baseline)were observed in some of the functioning or symptom scales; none of the QOL scales showed either “moderate” or “very much” change (i.e., ≥ 11 point difference from baseline). When examining the best change in each QOL domain from baseline, scales related to some aspects of functioning, global health status/QOL, and most symptoms revealed significant improvements (p < 0.05). Throughout the course of first-line palliative chemotherapy, most patients' QOL was maintained to a similar degree, regardless of their actual response to chemotherapy. CONCLUSION: This observational study provides important information on the chemotherapy patterns and QOL changes in Korean patientswith advanced GC. Overall, first-line palliative chemotherapy was found to maintain QOL, and most parameters showed an improvement compared with the baseline at some point during the course.
Disease-Free Survival
;
Drug Therapy*
;
Drug Therapy, Combination
;
Global Health
;
Humans
;
Korea
;
Observational Study
;
Prospective Studies
;
Quality of Life*
;
Stomach Neoplasms*
;
Weights and Measures
9.Effect of Korean Herbal Formula (Modified Ojayeonjonghwan) on Androgen Receptor Expression in an Aging Rat Model of Late Onset Hypogonadism.
Sae Woong CHOI ; Seung Hwan JEON ; Eun Bi KWON ; Guan Qun ZHU ; Kyu Won LEE ; Jin Bong CHOI ; Hyun Cheol JEONG ; Kang Sup KIM ; Sang Rak BAE ; Woong Jin BAE ; Su Jin KIM ; Hyuk Jin CHO ; U Syn HA ; Sung Hoo HONG ; Sung Yeoun HWANG ; Sae Woong KIM
The World Journal of Men's Health 2019;37(1):105-112
PURPOSE: Testosterone replacement therapy is an effective treatment for late-onset hypogonadism (LOH) despite a few contraindications and side-effects. The aim of this study was to determine whether modified Ojayeonjonghwan (KH-204, Korean herbal formula) improved LOH. KH-204 is a strong antioxidant herbal formula. We evaluated the effect of Korean herbal prescription on androgen receptor (AR) expression in an aged rat model of LOH. MATERIALS AND METHODS: Eighteen-month-old rats were used as aged LOH rat models. Eighteen Sprague-Dawley rats were randomly divided into three equal groups of six animals each and treated with one of the following: 1) normal control group (oral administration with distilled water, n=6), 2) KH-204 200 group (oral administration with 200 mg/kg of KH-204, n=6), and 3) KH-204 400 group (oral administration with 400 mg/kg of KH-204, n=6). After four weeks of treatment (once daily, distilled water or KH-204), serum testosterone levels, changes in testicular and epididymal weight, Western blotting analysis of AR expression and measurement of oxidative stress were examined. RESULTS: Treatment with the herbal formulation KH-204 200 mg/kg and 400 mg/kg (1) increased the weights of testis and epididymis; (2) increased the level of serum testosterone; (3) increased the level of superoxide dismutase and reduced the level of 8-hydroxy-20-deoxyguanosine; and (4) upregulated AR expression in testicular tissue. CONCLUSIONS: KH-204 might be an effective alternative for LOH. It improves antioxidant mechanisms and increases testicular AR expression without side-effects.
Aging*
;
Animals
;
Blotting, Western
;
Epididymis
;
Hypogonadism*
;
Male
;
Models, Animal*
;
Oxidative Stress
;
Phytotherapy
;
Prescriptions
;
Rats*
;
Rats, Sprague-Dawley
;
Receptors, Androgen*
;
Superoxide Dismutase
;
Testis
;
Testosterone
;
Water
;
Weights and Measures
10.Randomized Open Label Phase III Trial of Irinotecan Plus Capecitabine versus Capecitabine Monotherapy in Patients with Metastatic Breast Cancer Previously Treated with Anthracycline and Taxane: PROCEED Trial (KCSG BR 11-01).
In Hae PARK ; Seock Ah IM ; Kyung Hae JUNG ; Joo Hyuk SOHN ; Yeon Hee PARK ; Keun Seok LEE ; Sung Hoon SIM ; Kyong Hwa PARK ; Jee Hyun KIM ; Byung Ho NAM ; Hee Jun KIM ; Tae Yong KIM ; Kyung Hun LEE ; Sung Bae KIM ; Jin Hee AHN ; Suee LEE ; Jungsil RO
Cancer Research and Treatment 2019;51(1):43-52
PURPOSE: We investigated whether irinotecan plus capecitabine improved progression-free survival (PFS) compared with capecitabine alone in patients with human epidermal growth factor 2 (HER2) negative and anthracycline and taxane pretreated metastatic breast cancer (MBC). MATERIALS AND METHODS: A total of 221 patients were randomly assigned to irinotecan (80 mg/m2, days 1 and 8) and capecitabine (1,000 mg/m2 twice a day, days 1-14) or capecitabine alone (1,250 mg/m2 twice a day, days 1-14) every 3 weeks. The primary endpoint was PFS. RESULTS: There was no significant difference in PFS between the combination and monotherapy arm (median, 6.4 months vs. 4.7 months; hazard ratio [HR], 0.84; 95% confidence interval [CI], 0.63 to 1.11; p=0.84). In patients with triple-negative breast cancer (TNBC, n=90), the combination significantly improved PFS (median, 4.7 months vs. 2.5 months; HR, 0.58; 95% CI, 0.37 to 0.91; p=0.02). Objective response rate was numerically higher in the combination arm, though it failed to reach statistical significance (44.4% vs. 33.3%, p=0.30). Overall survival did not differ between arms (median, 20.4 months vs. 24.0 months; p=0.63). While grade 3 or 4 neutropenia was more common in the combination arm (39.6% vs. 9.0%), hand-foot syndrome was more often observed in capecitabine arm. Quality of life measurements in global health status was similar. However, patients in the combination arm showed significantly worse symptom scales especially in nausea/vomiting and diarrhea. CONCLUSION: Irinotecan plus capecitabine did not prove clinically superior to single-agent capecitabine in anthracycline- and taxane-pretreated HER2 negative MBC patients. Toxicity profiles of the two groups differed but were manageable. The role of added irinotecan in patients with TNBC remains to be elucidated.
Arm
;
Breast Neoplasms*
;
Breast*
;
Capecitabine*
;
Diarrhea
;
Disease-Free Survival
;
Epidermal Growth Factor
;
Global Health
;
Hand-Foot Syndrome
;
Humans
;
Neutropenia
;
Quality of Life
;
Triple Negative Breast Neoplasms
;
Weights and Measures


Result Analysis
Print
Save
E-mail